Cvs Health (CVS) Cash from Investing Activities (2009 - 2026)

Cvs Health has reported Cash from Investing Activities for 18 years, with the latest figure at -$874.0 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Investing Activities fell 14.7% year-over-year to -$874.0 million; the trailing twelve-month figure through Mar 2026 stood at -$6.0 billion (up 4.74% YoY), and the FY2025 full-year result was -$5.9 billion, up 22.88% from the prior year.
• Cash from Investing Activities for Q1 2026 stood at -$874.0 million, up from -$2.0 billion in the prior quarter.
• The five-year high for Cash from Investing Activities was -$119.0 million in Q4 2022, with the low at -$10.4 billion in Q2 2023.
• Historically, Cash from Investing Activities has averaged -$2.4 billion across 5 years, with a median of -$1.6 billion in 2024.
• Annual changes were most pronounced in 2022 — Cash from Investing Activities soared 91.74% — and 2023, when it slumped 943.7%.
• Cvs Health's Cash from Investing Activities stood at -$119.0 million in 2022, then tumbled by 943.7% to -$1.2 billion in 2023, then surged by 55.96% to -$547.0 million in 2024, then slumped by 265.27% to -$2.0 billion in 2025, then jumped by 56.26% to -$874.0 million in 2026.
• The last three Cash from Investing Activities figures came in at -$874.0 million (Q1 2026), -$2.0 billion (Q4 2025), and -$2.1 billion (Q3 2025), per Business Quant data.